Form 4 for HAE HAEMONETICS CORP
Accepted 2023-09-07 00:00:00 ET · period of report 2023-09-05 · accession 0001127602-23-023851 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-07 | 2023-09-05 | HAE | Dockendorff Charles J | Dir | S - Sale | $87.68 | -10.2K | 2,226 | -82% | -$895.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-05 | S | D | 10,215 | $87.68 | 2,226 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.19 to $88.01, inclusive. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. (F3) This number includes unvested restricted stock units previously reported. |